黄连解毒汤治疗帕金森病认知功能障碍患者临床研究OA
Clinical Study on Huanglian Jiedu Decoction(黄连解毒汤)in Treatment of Parkinson's Disease Patients with Cognitive Impairment
目的 探讨黄连解毒汤对治疗帕金森病(Parkinson's disease,PD)认知功能障碍患者神经营养因子、脑神经递质及临床疗效的影响.方法 选自医院2021年2月—2023年2月PD认知功能障碍患者120例,依据随机数表法分为治疗组与对照组,每组60例.对照组常规西医治疗,治疗组在对照组基础上结合黄连解毒汤.两组治疗周期12周.比较两组治疗12周临床疗效,治疗前与治疗12周认知功能、病情程度和日常生活活动能力、神经营养因子、脑神经递质及生活质量影响.结果 治疗组总有效率高于对照组(P<0.05).治疗12周,两组简易精神状况(Mini-mental state examina-tion,MMSE)评分和蒙特利尔认知评估量表(montreal cognitive assessment,MoCA)评分高于治疗前(P<0.05);治疗组MMSE评分和MoCA评分高于对照组(P<0.05).治疗12周,两组帕金森评分量表(unified Parkinson's disease rating scale,UPDRS)量表评分低于治疗前,且治疗组低于对照组(P<0.05);两组日常生活活动能力(Activities of Daily Living,ADL)评分高于治疗前,且观察组高于对照组(P<0.05).治疗12周,两组脑源性神经营养因子(Brain-derived neurotro-phic factor,BDNF)和胶质细胞源性神经营养因子(glial cell line derived neurotrophic factor,GDNF)水平高于治疗前(P<0.05);治疗组BDNF和GDNF水平高于对照组(P<0.05).治疗12周,两组同型半胱氨酸(Homocysteine,Hcy)和乙酰胆碱酯酶(acetylcholinesterase,AChE)水平低于治疗前,且治疗组低于对照组(P<0.05);两组乙酰胆碱(acetylcholine,Ach)水平高于治疗前,且治疗组高于对照组(P<0.05).治疗12周,两组帕金森生活质量量表(Parkinson's disease qual-ity of life questionnaire,PDQ-39)量表评分低于治疗前(P<0.05);治疗组PDQ-39量表评分低于对照组(P<0.05).结论 黄连解毒汤可提高PD认知功能障碍患者神经营养因子BDNF和GDNF水平,下调神经递质Hcy和AChE水平,上调Ach水平,疗效显著,且可改善认知功能和生活质量.
Objective To explore the effect of Huanglian Jiedu Decoction(黄连解毒汤)on neurotrophin,brain neurotransmit-ters and clinical efficacy in the treatment of Parkinson's disease(PD)patients with cognitive impairment.Method:A total of 120 PD patients with cognitive impairment admitted the hospital from February 2021 to February 2023 were divided into treatment group(60 cases)and control group(60 cases).The control group was treated with western medicine and the treatment group was combined with Huanglian Jiedu Decoction on thee basis of the control group.The treatment period of the two groups lasted for 12 weeks.The clinical efficacy of the two groups after 12 weeks of treatment was compared,and the effects of cognitive function,de-gree of illness and activities of daily living,neurotrophin,brain neurotransmitters and quality of life before and after 12 weeks of treatment were compared.Result The effective rate of the treatment group was higher than that of the control group(P<0.05).After 12 weeks of treatment,the mini-mental state examination(MMSE)scores and Montreal cognitive assessment(MoCA)scores of the two groups were higher than those before treatment(P<0.05).The scores of the treatment group were higher than those of the control group(P<0.05).After 12 weeks of treatment,the unified Parkinson's disease rating scale(UPDRS)scores of the two groups were lower than those before treatment,and the score of the treatment group was lower than that of the control group(P<0.05).The activities of daily living(ADL)scores were higher than those before treatment(P<0.05)and the ADL score in the treatment group was higher than that of the control group(P<0.05).After 12 weeks of treatment,the levels of brain-derived neurotrophic factor(BDNF)and glial cell line derived neurotrophic factor(GDNF)in both groups were higher than those before treatment(P<0.05).The levels in the treatment group were higher than those in the control group(P<0.05).After 12 weeks of treatment,the levels of homocysteine(Hey)and acetylcholinesterase(AChE)in both groups were lower than those before treat-ment,and the levels of the treatment group were lower than those of the control group(P<0.05).The levels of acetylcholine(Ach)in both groups were higher than those before treatment,and the level of the treatment group was higher than that of the con-trol group(P<0.05).After 12 weeks of treatment,the scores of the Parkinson's disease quality of life questionnaire(PDQ-39)in both groups were lower than those before treatment(P<0.05).The score of the treatment group was lower than that of the con-trol group(P<0.05).Conclusion Huanglian Jiedu Decoction can increase the levels of BDNF and GDNF,down-regulate the levels of Hey and AChE,and up-regulate the level of Ach in the PD patients with cognitive impairment.It has significant effects,and can improve cognitive function and quality of life.
张哲;靳晓飞;武萌萌;曹利红;苏志伟
河北省中医院,河北 石家庄 050000河北省中医院,河北 石家庄 050000河北省中医院,河北 石家庄 050000河北省中医院,河北 石家庄 050000河北省中医院,河北 石家庄 050000
医药卫生
黄连解毒汤帕金森病认知功能障碍神经营养因子脑神经递质临床疗效
Huanglian Jiedu Decoction(黄连解毒汤)Parkinson's diseasecognitive impairmentneurotrophinbrain neuro-transmittersclinical efficacy
《辽宁中医杂志》 2026 (4)
98-101,4
国家中医药管理局全国名中医传承工作室建设项目(2018年)河北省中医药管理局科研计划项目(2020088)河北省自然科学基金项目(H2022423382)河北省中医药管理局科研计划项目(2021101)5.河北省研究生创新资助项目(CXZZBS2023138)
评论